- Status:
- Topic prioritisation
- Technology type:
- Medicine
- Decision:
- Further information required
- Prioritisation programme:
- Medicines evaluation
- Rationale:
Dear stakeholders,
For information, the company has not engaged with the NICE medicines selection team regarding this topic. Therefore, NICE has decided to suspend this appraisal from its current work programme.- ID number:
- 10620
Project Team
- Project lead
- Danielle Lees
Email enquiries
If you have any queries please email topic.selection@nice.org.uk
Related links
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 11 February 2026 | Note - Note added to the project documents |
For further information on how we select topics for development, please see our page about topic prioritisation